☆ 4.7 Article

Autoantibodies neutralizing type I IFNs are present in ∼4% of uninfected individuals over 70 years old and account for ∼20% of COVID-19 deaths

SCIENCE IMMUNOLOGY (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Multidisciplinary Sciences

A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate

Lorena Sanchez-Felipe et al.

Summary: The candidate vaccine YF-S0, utilizing the YF17D vaccine as a vector to express noncleavable prefusion form of the SARS-CoV-2 spike antigen, showed excellent safety, immunogenicity, and efficacy in animal models. It induced high levels of neutralizing antibodies, provided protective immunity against SARS-CoV-2, and prevented infection in hamsters and macaques. A single dose was able to confer protection from lung disease in most vaccinated hamsters within 10 days, highlighting the potential of YF-S0 as a potent SARS-CoV-2 vaccine candidate.

NATURE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Immune determinants of COVID-19 disease presentation and severity

Petter Brodin

Summary: The severity of COVID-19 varies by sex and age, and is linked to comorbidities. Differences in immune reactions may go some way to explain this.

NATURE MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

D. M. Weinreich et al.

Summary: Recent data indicate that complications and death from Covid-19 may be related to high viral loads. In this trial involving nonhospitalized patients, a cocktail of two neutralizing monoclonal antibodies (REGN-COV2) reduced viral load, with a greater effect in patients with no immune response or high viral load at baseline. Safety outcomes were similar between REGN-COV2 dose groups and the placebo group.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

Peter Chen et al.

Summary: LY-CoV555, a neutralizing antibody, showed promising results in reducing viral load, improving symptoms, and lowering the risk of hospitalization among patients with mild or moderate Covid-19. While one of the doses appeared to accelerate the decline in viral load, others did not show significant effects by day 11.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Immunology

Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia

Nicolas de Prost et al.

Summary: This study reported four cases of life-threatening COVID-19 pneumonia in patients with high blood concentrations of neutralizing autoantibodies against type I interferons, who were treated with plasma exchange. The results showed that plasma exchange efficiently removes autoantibodies against type I interferons in these patients without affecting anti-SARS-CoV-2 antibody levels.

JOURNAL OF CLINICAL IMMUNOLOGY (2021)

添加到收藏夹

Article Immunology

Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine

Paul Bastard et al.

Summary: In rare cases, yellow fever virus (YFV) live attenuated vaccine can cause life-threatening disease, particularly in patients with no history of severe viral illness. Some patients with auto-Abs against multiple type I interferons and autosomal recessive IFNAR1 or IFNAR2 deficiency were found to be at risk of developing severe complications after YFV vaccination. Testing for these predispositions could be considered for healthy individuals before YFV vaccination.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

添加到收藏夹

Article Critical Care Medicine

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial

Phillip D. Monk et al.

Summary: The study evaluated the efficacy and safety of using interferon beta-1a to treat COVID-19, with results showing that patients who received treatment had higher and faster recovery rates, providing potential evidence for further clinical trials.

LANCET RESPIRATORY MEDICINE (2021)

添加到收藏夹

Letter Critical Care Medicine

Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients

Rutger Koning et al.

INTENSIVE CARE MEDICINE (2021)

添加到收藏夹

Letter Immunology

Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma

Sara E. Vazquez et al.

JOURNAL OF CLINICAL IMMUNOLOGY (2021)

添加到收藏夹

Article Immunology

Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain

Jesus Troya et al.

Summary: In severe cases of COVID-19 pneumonia, approximately 10.6% of patients were found to have autoantibodies neutralizing type I IFN, which correlated with increased C-reactive protein levels and decreased lymphocyte counts, possibly increasing the risk of death. Subcutaneous IFN-beta treatment did not seem to improve clinical outcomes.

JOURNAL OF CLINICAL IMMUNOLOGY (2021)

添加到收藏夹

Letter Immunology

Interferon-β Therapy in a Patient with Incontinentia Pigmenti and Autoantibodies against Type I IFNs Infected with SARS-CoV-2

Paul Bastard et al.

JOURNAL OF CLINICAL IMMUNOLOGY (2021)

添加到收藏夹

Article Immunology

Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1

Paul Bastard et al.

Summary: Patients with biallelic loss-of-function variants of AIRE, suffering from APS-1, produce autoantibodies that neutralize most type I interferons, leading to a significantly increased risk of life-threatening COVID-19 pneumonia. Research has shown that in APS-1 patients with these neutralizing autoantibodies, 86% developed COVID-19 pneumonia.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Diverse functional autoantibodies in patients with COVID-19

Eric Y. Wang et al.

Summary: COVID-19 patients show increased autoantibody reactivities against immunomodulatory proteins, which may affect immune function and lead to different clinical outcomes.

NATURE (2021)

添加到收藏夹

Article Immunology

X-linked recessive TLR7 deficiency in ∼1% of men under 60 years old with life-threatening COVID-19

Takaki Asano et al.

Summary: A study revealed that rare X-linked TLR7 variants were found in 16 unrelated male individuals with critical COVID-19 pneumonia out of a cohort of 1202 male patients. No such variants were detected in 331 asymptomatic or mildly infected male individuals.

SCIENCE IMMUNOLOGY (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1

Christian Meisel et al.

Summary: This study found that patients with APS-1 and preexisting neutralizing autoantibodies against IFN-alpha and IFN-omega developed only mild symptoms of COVID-19 after contracting SARS-CoV-2, without progressing to severe cases. These patients were mostly female and under the age of 26.

JOURNAL OF CLINICAL INVESTIGATION (2021)

添加到收藏夹

Review Genetics & Heredity

COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy

Giuseppe Novelli et al.

Summary: COVID-19 has spread worldwide and after a year, we have more tools to deal with the pandemic, but it requires a stronger sense of community and avoiding local politics to hinder global cooperation.

HUMAN GENOMICS (2021)

添加到收藏夹

Article Rheumatology

Is the epidemiology of rheumatoid arthritis changing? Results from a population-based incidence study, 1985-2014

Elena Myasoedova et al.

ANNALS OF THE RHEUMATIC DISEASES (2020)

添加到收藏夹

Editorial Material Biochemistry & Molecular Biology

A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection

Jean-Laurent Casanova et al.

CELL (2020)

添加到收藏夹

Article Allergy

Type I IFN immunoprofiling in COVID-19 patients

Sophie Trouillet-Assant et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Factors associated with COVID-19-related death using OpenSAFELY

Elizabeth J. Williamson et al.

NATURE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Jerome Hadjadj et al.

SCIENCE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Qian Zhang et al.

SCIENCE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Paul Bastard et al.

SCIENCE (2020)

添加到收藏夹

Review Public, Environmental & Occupational Health

Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications

Andrew T. Levin et al.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Age-specific mortality and immunity patterns of SARS-CoV-2

Megan O'Driscoll et al.

NATURE (2020)

添加到收藏夹

Review Immunology

Shared and Distinct Functions of Type I and Type III Interferons

Helen M. Lazear et al.

IMMUNITY (2019)

添加到收藏夹

Article Immunology

Neutralizing Anti-Cytokine Autoantibodies Against Interferon-α in Immunodysregulation Polyendocrinopathy Enteropathy X-Linked

Jacob M. Rosenberg et al.

FRONTIERS IN IMMUNOLOGY (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

AIRE-Deficient Patients Harbor Unique High-Affinity Disease-Ameliorating Autoantibodies

Steffen Meyer et al.

CELL (2016)

添加到收藏夹

Article Rheumatology

Distinct Functions of Autoantibodies Against Interferon in Systemic Lupus Erythematosus A Comprehensive Analysis of Anticytokine Autoantibodies in Common Rheumatic Diseases

Sarthak Gupta et al.

ARTHRITIS & RHEUMATOLOGY (2016)

添加到收藏夹

Article Medicine, Research & Experimental

Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency

Jolan E. Walter et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

添加到收藏夹

Article Medicine, General & Internal

Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1

Anthony Meager et al.

PLOS MEDICINE (2006)

添加到收藏夹

Article Medical Laboratory Technology

Simultaneous multiple immunoassays in a compact disc-shaped microfluidic device based on centrifugal force

N Honda et al.

CLINICAL CHEMISTRY (2005)

添加到收藏夹

Article Immunology

Characterization of the immunoreactivity of anti-interferon alpha antibodies in myasthenia gravis patients.: Epitope mapping

I Bello-Rivero et al.

JOURNAL OF AUTOIMMUNITY (2004)

添加到收藏夹

Article Immunology

Spontaneous production of anti-IFN-α and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor

H Shiono et al.

INTERNATIONAL IMMUNOLOGY (2003)

添加到收藏夹

Article Immunology

Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and/or myasthenia gravis

A Meager et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)

添加到收藏夹

Article Mathematical & Computational Biology

A solution to the problem of separation in logistic regression

G Heinze et al.

STATISTICS IN MEDICINE (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.